Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | 240,000 | reported | 05 Jan 2026 | tx 1+240,000 |
| CEMPRA, INC. | 30,000 | reported | 11 Jun 2019 | tx 7+329,100 |
| UNITED THERAPEUTICS Corp | 1,542 | reported | 13 May 2016 | tx 162+398,886−482,772 |
| Dova Pharmaceuticals, Inc. | 0 | reported | 12 Nov 2019 | tx 8+1,092,372−1,092,372 |
| Verona Pharma plc | 0 | reported | 07 Oct 2025 | tx 92+15,663,552−35,228,688 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jan 2026 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 240,000 | 0.00 USD | deriv |
| 07 Oct 2025 | OTHER | Verona Pharma plc | 3,285,280 | — | |
| 07 Oct 2025 | EXERCISE | Verona Pharma plc | 3,285,280 | — | |
| 07 Oct 2025 | OTHER | Verona Pharma plc | 12,176,144 | — | |
| 07 Oct 2025 | EXERCISE | Verona Pharma plc | 389,792 | — | deriv |
| 07 Oct 2025 | EXERCISE | Verona Pharma plc | 800,000 | — | deriv |
| 07 Oct 2025 | EXERCISE | Verona Pharma plc | 445,536 | — | deriv |
| 07 Oct 2025 | EXERCISE | Verona Pharma plc | 1,649,952 | — | deriv |
| 07 Oct 2025 | GRANT_AWARD | Verona Pharma plc | 1,649,952 | — | deriv |
| 29 Aug 2025 | GIFT | Verona Pharma plc | 1,200,000 | 0.00 USD | |
| 01 Aug 2025 | SALE | Verona Pharma plc | 208,912 | 13.14 USD | |
| 01 Aug 2025 | EXERCISE | Verona Pharma plc | 255,696 | 0.00 USD | |
| 01 Aug 2025 | EXERCISE | Verona Pharma plc | 55,696 | 0.00 USD | deriv |
| 01 Aug 2025 | EXERCISE | Verona Pharma plc | 200,000 | 0.00 USD | deriv |
| 08 Jul 2025 | TAX_WITHHOLDING | Verona Pharma plc | 90,320 | 11.44 USD | |
| 07 Jul 2025 | EXERCISE | Verona Pharma plc | 229,512 | 0.00 USD | |
| 07 Jul 2025 | GRANT_AWARD | Verona Pharma plc | 675,048 | 0.00 USD | deriv |
| 07 Jul 2025 | EXERCISE | Verona Pharma plc | 229,512 | 0.00 USD | deriv |
| 11 Jun 2025 | SALE | Verona Pharma plc | 400,000 | 11.40 USD | |
| 29 May 2025 | SALE | Verona Pharma plc | 208,696 | 9.33 USD | |
| 27 May 2025 | SALE | Verona Pharma plc | 33,600 | 9.53 USD | |
| 28 May 2025 | SALE | Verona Pharma plc | 157,704 | 9.30 USD | |
| 01 May 2025 | EXERCISE | Verona Pharma plc | 200,000 | — | |
| 02 May 2025 | SALE | Verona Pharma plc | 400,000 | 9.09 USD | |
| 01 May 2025 | SALE | Verona Pharma plc | 78,736 | 8.95 USD |